KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 128 filers reported holding KEZAR LIFE SCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,500,970 | -51.4% | 5,463,000 | 0.0% | 0.14% | -43.2% |
Q2 2023 | $13,384,350 | -21.7% | 5,463,000 | 0.0% | 0.24% | -27.7% |
Q1 2023 | $17,099,190 | -47.0% | 5,463,000 | +19.2% | 0.34% | -45.5% |
Q4 2022 | $32,273,627 | +111.6% | 4,584,322 | +158.8% | 0.62% | +118.0% |
Q3 2022 | $15,254,000 | +29.9% | 1,771,700 | +24.8% | 0.28% | +32.9% |
Q2 2022 | $11,743,000 | +7.6% | 1,419,900 | +12.4% | 0.21% | +77.5% |
Q3 2021 | $10,916,000 | +260.7% | 1,263,400 | +126.7% | 0.12% | +287.1% |
Q2 2021 | $3,026,000 | – | 557,191 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |